Biohaven Pharmaceutical Holding Co Ltd. 4 SEC Filings

Filed On	Filing
05 Oct 2022	Form 4: Biohaven Pharmaceutical Holding Co Ltd., 10% owner · Biohaven Ltd. Acquired 35,839,857 shares (Other Transaction) · Disposed of 35,839,857 shares (Other Transaction)
03 Oct 2022	Form 4: Childs John W, Director Returned 3,035,001 shares to the issuer ($451M) · Disposed of 20,235 Stock Options (Right to Buy) (Disposition to Issuer)
03 Oct 2022	Form 4: Buten Matthew, Chief Financial Officer Returned 6,177 shares to the issuer ($917K) · Disposed of 37,500 Restricted Share Unit Award (Disposition to Issuer) · Disposed of 26,000 Stock Options (Right to Buy) (Disposition to Issuer)
03 Oct 2022	Form 4: Mehta Kishan, Director Returned 10,640 shares to the issuer ($1.58M) · Disposed of 1,875 Restricted Share Unit Award (Disposition to Issuer) · Disposed of 56,243 Stock Options (Right to Buy) (Disposition to Issuer)
03 Oct 2022	Form 4: Tilton John, Chief Commercial Officer Returned 6,682 shares to the issuer ($992K) · Disposed of 6,375 Restricted Share Unit Award (Disposition to Issuer) · Disposed of 120,032 Stock Options (Right to Buy) (Disposition to Issuer)
03 Oct 2022	Form 4: Coric Vlad, Director Returned 922,941 shares to the issuer ($137M) · Disposed of 105,954 Restricted Share Unit Award (Disposition to Issuer) · Disposed of 1,172,500 Stock Options (Right to Buy) (Disposition to Issuer)
03 Oct 2022	Form 4: Heffernan Michael Thomas, Director Disposed of 3,320 Restricted Share Unit Award (Disposition to Issuer) · Disposed of 46,435 Stock Options (Right to Buy) (Disposition to Issuer)
03 Oct 2022	Form 4: Gregory Julia P, Director Disposed of 56,235 Stock Options (Right to Buy) (Disposition to Issuer)
03 Oct 2022	Form 4: Jones William A Jr, CCO-Migraine & Common Disease Returned 14,226 shares to the issuer ($2.11M) · Disposed of 24,250 Restricted Share Unit Award (Disposition to Issuer) · Disposed of 150,000 Stock Options (Right to Buy) (Disposition to Issuer)
03 Oct 2022	Form 4: Hugin Robert J, Director Returned 2,900 shares to the issuer ($431K) · Disposed of 3,417 Restricted Share Unit Award (Disposition to Issuer) · Disposed of 39,183 Stock Options (Right to Buy) (Disposition to Issuer)
03 Oct 2022	Form 4: Antonijevic Irina, Director Disposed of 5,070 Restricted Share Unit Award (Disposition to Issuer)
03 Oct 2022	Form 4: Clark George C., VP, Chief Accounting Officer Returned 4,292 shares to the issuer ($637K) · Disposed of 21,750 Restricted Share Unit Award (Disposition to Issuer) · Disposed of 33,375 Stock Options (Right to Buy) (Disposition to Issuer)
03 Oct 2022	Form 4: Bailey Gregory, Director Returned 2,583,658 shares to the issuer ($384M) · Disposed of 56,235 Stock Options (Right to Buy) (Disposition to Issuer)
03 Oct 2022	Form 4: Stock Elyse, Chief Medical Officer Returned 16,464 shares to the issuer ($2.44M) · Disposed of 27,063 Restricted Share Unit Award (Disposition to Issuer) · Disposed of 175,788 Stock Options (Right to Buy) (Disposition to Issuer)
03 Oct 2022	Form 4: Conway Charles, Chief Scientific Officer Returned 22,362 shares to the issuer ($3.32M) · Disposed of 22,000 Restricted Share Unit Award (Disposition to Issuer) · Disposed of 252,727 Stock Options (Right to Buy) (Disposition to Issuer)
03 Oct 2022	Form 4: Engelhart James, Strategic Advisor Returned 15,900 shares to the issuer ($2.36M) · Disposed of 20,950 Restricted Share Unit Award (Disposition to Issuer) · Disposed of 278,764 Stock Options (Right to Buy) (Disposition to Issuer) · 1 more
03 Oct 2022	Form 4: Gentile Kimberly, SVP, Clinical Operations Returned 11,653 shares to the issuer ($1.73M) · Disposed of 24,250 Restricted Share Unit Award (Disposition to Issuer) · Disposed of 231,022 Stock Options (Right to Buy) (Disposition to Issuer)
22 Aug 2022	Form 4: Bailey Gregory, Director Bought 38,000 shares ($5.63M)
12 May 2022	Form 4: Antonijevic Irina, Director Granted 5,070 Restricted Share Unit Award
12 May 2022	Form 4: Clark George C., VP, Chief Accounting Officer Received 2,250 shares by exercise or conversion ($121K) · Sold 4,200 shares ($594K)

05 Oct 2022

Form 4: Biohaven Pharmaceutical Holding Co Ltd., 10% owner · Biohaven Ltd.

Acquired 35,839,857 shares (Other Transaction) · Disposed of 35,839,857 shares (Other Transaction)

03 Oct 2022

Returned 3,035,001 shares to the issuer ($451M) · Disposed of 20,235 Stock Options (Right to Buy) (Disposition to Issuer)

03 Oct 2022

Form 4: Buten Matthew, Chief Financial Officer

Returned 6,177 shares to the issuer ($917K) · Disposed of 37,500 Restricted Share Unit Award (Disposition to Issuer) · Disposed of 26,000 Stock Options (Right to Buy) (Disposition to Issuer)

03 Oct 2022

Form 4: Mehta Kishan, Director

Returned 10,640 shares to the issuer ($1.58M) · Disposed of 1,875 Restricted Share Unit Award (Disposition to Issuer) · Disposed of 56,243 Stock Options (Right to Buy) (Disposition to Issuer)

03 Oct 2022

Form 4: Tilton John, Chief Commercial Officer

Returned 6,682 shares to the issuer ($992K) · Disposed of 6,375 Restricted Share Unit Award (Disposition to Issuer) · Disposed of 120,032 Stock Options (Right to Buy) (Disposition to Issuer)

03 Oct 2022

Form 4: Coric Vlad, Director

Returned 922,941 shares to the issuer ($137M) · Disposed of 105,954 Restricted Share Unit Award (Disposition to Issuer) · Disposed of 1,172,500 Stock Options (Right to Buy) (Disposition to Issuer)

03 Oct 2022

Form 4: Heffernan Michael Thomas, Director

Disposed of 3,320 Restricted Share Unit Award (Disposition to Issuer) · Disposed of 46,435 Stock Options (Right to Buy) (Disposition to Issuer)

03 Oct 2022

Form 4: Gregory Julia P, Director

Disposed of 56,235 Stock Options (Right to Buy) (Disposition to Issuer)

03 Oct 2022

Form 4: Jones William A Jr, CCO-Migraine & Common Disease

Returned 14,226 shares to the issuer ($2.11M) · Disposed of 24,250 Restricted Share Unit Award (Disposition to Issuer) · Disposed of 150,000 Stock Options (Right to Buy) (Disposition to Issuer)

03 Oct 2022

Form 4: Hugin Robert J, Director

Returned 2,900 shares to the issuer ($431K) · Disposed of 3,417 Restricted Share Unit Award (Disposition to Issuer) · Disposed of 39,183 Stock Options (Right to Buy) (Disposition to Issuer)

03 Oct 2022

Form 4: Antonijevic Irina, Director

Disposed of 5,070 Restricted Share Unit Award (Disposition to Issuer)

03 Oct 2022

Form 4: Clark George C., VP, Chief Accounting Officer

Returned 4,292 shares to the issuer ($637K) · Disposed of 21,750 Restricted Share Unit Award (Disposition to Issuer) · Disposed of 33,375 Stock Options (Right to Buy) (Disposition to Issuer)

03 Oct 2022

Form 4: Bailey Gregory, Director

Returned 2,583,658 shares to the issuer ($384M) · Disposed of 56,235 Stock Options (Right to Buy) (Disposition to Issuer)

03 Oct 2022

Form 4: Stock Elyse, Chief Medical Officer

Returned 16,464 shares to the issuer ($2.44M) · Disposed of 27,063 Restricted Share Unit Award (Disposition to Issuer) · Disposed of 175,788 Stock Options (Right to Buy) (Disposition to Issuer)

03 Oct 2022

Form 4: Conway Charles, Chief Scientific Officer

Returned 22,362 shares to the issuer ($3.32M) · Disposed of 22,000 Restricted Share Unit Award (Disposition to Issuer) · Disposed of 252,727 Stock Options (Right to Buy) (Disposition to Issuer)

03 Oct 2022

Form 4: Engelhart James, Strategic Advisor

Returned 15,900 shares to the issuer ($2.36M) · Disposed of 20,950 Restricted Share Unit Award (Disposition to Issuer) · Disposed of 278,764 Stock Options (Right to Buy) (Disposition to Issuer) · 1 more

03 Oct 2022

Form 4: Gentile Kimberly, SVP, Clinical Operations

Returned 11,653 shares to the issuer ($1.73M) · Disposed of 24,250 Restricted Share Unit Award (Disposition to Issuer) · Disposed of 231,022 Stock Options (Right to Buy) (Disposition to Issuer)

22 Aug 2022

Form 4: Bailey Gregory, Director

Bought 38,000 shares ($5.63M)

12 May 2022

Form 4: Antonijevic Irina, Director

Granted 5,070 Restricted Share Unit Award

12 May 2022

Form 4: Clark George C., VP, Chief Accounting Officer

Received 2,250 shares by exercise or conversion ($121K) · Sold 4,200 shares ($594K)